Results 241 to 250 of about 5,272,673 (396)

Editorial: Disabled people's health

open access: yesFrontiers in Public Health
Saengryeol Park   +4 more
openaire   +3 more sources

Botulinum Toxin Efficacy in Upper Limb Tremor: A Systematic Review and Meta‐Analysis

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Essential tremor (ET) and dystonic tremor syndrome (DTS) can be treated using botulinum toxin (BoNT) injections. Previous reviews lacked an assessment of the certainty of evidence and focused solely on clinician‐reported outcomes. Additionally, studies have demonstrated interindividual variability in BoNT efficacy. Objective The aim
Iris M. Visser   +5 more
wiley   +1 more source

Empowering and conquering infirmity of visually impaired using AI‐technology equipped with object detection and real‐time voice feedback system in healthcare application

open access: yesCAAI Transactions on Intelligence Technology, EarlyView., 2023
Abstract The Internet of Things is emerging as a crucial technology in aiding humans and making their lives easier. Among the human population, a large percentage of people suffer from disabilities resulting in challenges in everyday life particularly people with visual disabilities.
Hania Tarik   +8 more
wiley   +1 more source

Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) is an established treatment for Parkinson's disease (PD) in appropriately selected patients. DBS may be underused in certain patient populations, especially women and racialized groups. Barriers and biases to receiving DBS that could account for underuse among these groups are not well studied in Canada.
Fang Ba   +14 more
wiley   +1 more source

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy